Protalix BioTherapeutics
PLX
PLX
35 hedge funds and large institutions have $56.7M invested in Protalix BioTherapeutics in 2015 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
Holders
35
Holding in Top 10
–
Calls
$233K
Puts
$96K
Top Buyers
| 1 | +$14.2M | |
| 2 | +$4.88M | |
| 3 | +$416K | |
| 4 |
Jane Street
New York
|
+$208K |
| 5 |
VanEck Associates
New York
|
+$114K |
Top Sellers
| 1 | -$10M | |
| 2 | -$3.11M | |
| 3 | -$2.93M | |
| 4 |
BG
BlackRock Group
London,
United Kingdom
|
-$862K |
| 5 |
BlackRock
New York
|
-$604K |